CSCI – cosciens biopharma inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CSCI

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/15

05:29 am

csci

COSCIENS Biopharma Third Quarter 2024 Earnings: US$1.85 loss per share (vs US$3.41 loss in 3Q 2023) [Yahoo! Finance]

Low Report

COSCIENS Biopharma Third Quarter 2024 Earnings: US$1.85 loss per share (vs US$3.41 loss in 3Q 2023) [Yahoo! Finance]

Report

11/12

07:30 am

csci

COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs

High Report

COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs

Report

10/8

07:30 am

csci

COSCIENS Biopharma Announces Change to Board of Directors

Neutral Report

COSCIENS Biopharma Announces Change to Board of Directors

Report

10/1

05:42 pm

csci

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director [Yahoo! Finance]

Low Report

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director [Yahoo! Finance]

Report

10/1

05:39 pm

csci

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director [Financial Post (Toronto, Ontario, Canada)]

Low Report

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director [Financial Post (Toronto, Ontario, Canada)]

Report

10/1

05:30 pm

csci

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director

Low Report

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director

Report

9/23

07:36 am

csci

COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs [Financial Post (Toronto, Ontario, Canada)]

Medium Report

COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs [Financial Post (Toronto, Ontario, Canada)]

Report

9/23

07:30 am

csci

COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs

Medium Report

COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.